In this randomised , open-label , non-inferiority trial , we recruited patients aged 18 years and older with chronic HIV-1 infection and no previous treatment failure or resistance , and with HIV-1 RNA of less than 50 copies per mL for at least 6 months , negative hepatitis B virus surface antigen , and good general health , from 30 hospitals in Spain .